- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05403008
Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Statement of the problem:
The glass ionomer restorations have a wide use in dental community. Proximal restoration is a challenge, due to the high forces present in this area that require more high fracture resistance restoration material which is not obtained in the most of the versions of glass ionomer restorations that are available in dental market.(Safy, 2019)
Rationale for choice of intervention:
Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor, zirconomer. Zirconomer is commercialized as a white amalgam as it features mechanical properties similar to amalgam restorations. In this generation also, translucency is improved to be similar to the tooth structure.(Shetty et al, 2017) As Zirconomer improved is reinforced material, it is expected that has high wear resistance than the conventional glass ionomer restorations. (Hesse et al., 2018)
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: weaam mohamed ammar, master
- Phone Number: 00201009432333
- Email: weaam.abdelfatah@dentistry.cu.edu.eg
Study Contact Backup
- Name: Rawda Hesham Abd ElAziz, PhD
- Phone Number: +21001097200
- Email: rawda.hesham@dentistry.cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age group 18-55
- Presence of occluding tooth.
- Good oral hygiene
Exclusion Criteria:
- Poor periodontal status
- Adverse medical history.
- Potential behavioral problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Zirconomer improved
a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
|
Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
|
|
Active Comparator: Nano hybird resin composite
Resin composite (RC) is the gold standard esthetic restoration in proximal cavities due to their high aesthetic properties, increased mechanical durability and enhanced adhesion to tooth structure.
|
Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Postoperative Hypersensitivity Secondary caries
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Secondary caries and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Gross fracture and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Color match and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Cavo-surface marginal discoloration and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Marginal integrity and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
|
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
|
Proximal contact and measured by Modified United States Public Health Service Criteria (USPHS)
|
Change from the baseline at 6 months and at 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wear resistance evaluation
Time Frame: Change from the baseline at 6 months and at 12 months.
|
"Wear measurements Measured by using WSxM software.
|
Change from the baseline at 6 months and at 12 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ahmed El-Hoshy, Professor, Cairo university
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zirconomer Improved
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on Zirconomer improved
-
Al-Azhar UniversityCompleted
-
Cairo UniversityCompletedPerformance | GeriatricEgypt
-
Cairo UniversityActive, not recruitingContact Tightness in Restoring Proximal Surfaces in Posterior TeethEgypt
-
Hams Hamed AbdelrahmanCompleted
-
Boston CollegeWashington University School of Medicine; Sri Ramachandra UniversityActive, not recruitingChronic Obstructive Pulmonary Disease | Asthma
-
Massachusetts General HospitalAlliance for Clinical Trials in Oncology Cancer Control Program (CCP)CompletedCancerUnited States
-
International Centre for Diarrhoeal Disease Research...University of Chicago; National Institute of Environmental Health Sciences... and other collaboratorsRecruitingCardiovascular Diseases | Lung Diseases | Immune Dysfunction | Household Air PolutionBangladesh
-
London School of Hygiene and Tropical MedicineCompletedDiarrhea | CholeraCongo, The Democratic Republic of the
-
Massachusetts General HospitalCompleted
-
Johns Hopkins Bloomberg School of Public HealthBrown University; National Institutes of Health (NIH); Universidad Peruana Cayetano... and other collaboratorsCompletedRespiratory Conditions Due to Other External Agents | Poisoning by Carbon Monoxide From Domestic FuelsKenya, Nepal, Peru